Medifast Inc financial data

Symbol
MED on NYSE
Location
11445 Cronhill Drive, Owings Mills, MD
State of incorporation
DE
Fiscal year end
December 31
Former names
HEALTHRITE INC (to 1/9/2001)
Latest financial report
10-K - Q4 2024 - Feb 18, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 306 % +51.3%
Quick Ratio 58.3 % -6.06%
Debt-to-equity 40.6 % -41.4%
Return On Equity 1 % -98.1%
Return On Assets 0.71 % -97.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 10.9M shares +0.39%
Common Stock, Shares, Outstanding 10.9M shares +0.39%
Entity Public Float 230M USD -77%
Common Stock, Value, Issued 11K USD 0%
Weighted Average Number of Shares Outstanding, Basic 10.9M shares +0.42%
Weighted Average Number of Shares Outstanding, Diluted 11M shares +0.39%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 602M USD -43.8%
Cost of Revenue 158M USD -46.7%
Operating Income (Loss) 2.88M USD -97.7%
Nonoperating Income (Expense) 909K USD -62%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3.79M USD -97.1%
Income Tax Expense (Benefit) 1.7M USD -94.2%
Net Income (Loss) Attributable to Parent 2.09M USD -97.9%
Earnings Per Share, Basic 0.19 USD/shares -97.9%
Earnings Per Share, Diluted 0.19 USD/shares -97.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 90.9M USD -3.72%
Cash, Cash Equivalents, and Short-term Investments 166M USD +11%
Inventory, Net 42.4M USD -22.3%
Assets, Current 214M USD -4.3%
Deferred Income Tax Assets, Net 11.5M USD +178%
Property, Plant and Equipment, Net 37.5M USD -27.1%
Operating Lease, Right-of-Use Asset 11.2M USD -28.7%
Other Assets, Noncurrent 9.67M USD -34%
Assets 284M USD -8.29%
Contract with Customer, Liability, Current 316K USD -44.9%
Liabilities, Current 64.2M USD -30.5%
Operating Lease, Liability, Noncurrent 9.94M USD -38.3%
Liabilities 74.1M USD -31.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 180K USD -27.4%
Retained Earnings (Accumulated Deficit) 177M USD +1.22%
Stockholders' Equity Attributable to Parent 210M USD +4.28%
Liabilities and Equity 284M USD -8.29%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 7.28M USD -88.6%
Net Cash Provided by (Used in) Financing Activities -1.49M USD +94.2%
Net Cash Provided by (Used in) Investing Activities -2.78M USD -31.2%
Common Stock, Shares Authorized 20M shares 0%
Common Stock, Shares, Issued 10.9M shares +0.39%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.03M USD -91.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 90.9M USD -3.72%
Deferred Tax Assets, Valuation Allowance 1.62M USD -3.33%
Deferred Tax Assets, Gross 20.5M USD +0.09%
Operating Lease, Liability 16.1M USD -26.7%
Payments to Acquire Property, Plant, and Equipment 1.84M USD -13%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 2.02M USD -98%
Lessee, Operating Lease, Liability, to be Paid 16.7M USD -27.5%
Property, Plant and Equipment, Gross 95.9M USD -2.94%
Operating Lease, Liability, Current 6.18M USD +5.05%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.78M USD -26%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.46M USD +2.38%
Operating Lease, Weighted Average Discount Rate, Percent 0.02 pure 0%
Deferred Income Tax Expense (Benefit) 112K USD -86%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 531K USD -44.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.55M USD -46.6%
Deferred Tax Assets, Operating Loss Carryforwards 2.73M USD -5.24%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1.5M shares 0%
Unrecognized Tax Benefits 7.43M USD -0.92%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.62M USD +2.55%
Operating Lease, Payments 1.56M USD -13.4%
Additional Paid in Capital 33.1M USD +24.7%
Depreciation, Depletion and Amortization 3.26M USD +9.65%
Share-based Payment Arrangement, Expense 7.36M USD -10.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%